Adherent murine stromal cells support long-term in vitro lymphopoiesis or myelopoiesis dependent on the culture conditions used. A cell line, TC-1, isolated from long-term liquid murine marrow cultures under conditions approaching those permissive for lymphoid growth, has been found t o produce an activity that acts synergistically with interleukin-3 (IL-3) or colony-stimulating factor-1 (CSF-1) t o stimulate in vitro myeloid colonies, but which has no intrinsic colony-stimulating activity. We report here the presence of multiple growth factors in conditioned medium (CM) from the TC-1 line, including granulocyte-macrophage colonystimulating factor (GM-CSF) (bioassay with antibody blocking and messenger RNA [mRNA] analysis), granulocyte CSF (G-CSF) and IL-4 (factor-dependent cell line bioassay), and CSF-1 (radioimmunoassay, mRNA) along with a pre-B cell inducing activity, which appears separate from these CSFs and segregates with the myeloid synergizing activity through anion exchange, sizing, and Conconavalin A chro-E HAVE PREVIOUSLY reported that a murine Th us, the possibility exists that any described bioactivity in a nonpurified mixture of molecules may represent the effects of mixtures of growth factors acting synergistically. In addition, since these synergisms may occur at very low concentrations of growth factors,2' a negative result in the primary growth factor assay does not necessarily indicate that a synergistic biologic effect is not mediated by a specific growth factor. Thus, it is important to define the growth factor activities produced by a matography. Because these activities are not yet purified t o homogeneity, their identity or lack of identity remains an open question. Assays of TC-1 CM or cellular mRNA analysis have given negative results for IL-1, IL-2, IL-3, IL-6, and IL-7, and IL-6 does not stimulate pre-B cells in this assay. However, IL-4 and G-CSF do stimulate in vitro induction of pre-B cells from pre-B and B-cell-depleted Balb/C marrow and are present in CM by selective cell line assay. A monoclonal antibody t o IL-4 that inhibited its pre-B inducing activity did not inhibit pre-B inducing activity of TC-1 CM. These data suggest the existence of a unique synergizing and pre-B inducing factor(s) in TC-1 CM. Given the known capacity of subliminal levels of growth factors t o act synergistically, an alternate possibility is that these biologic phenomena represent the actions of low concentrations of growth factors acting synergistically and possibly associated with some core protein. cell population and to consider the possibility of synergistic interactions between these growth factors.
Accordingly, we have continued our studies on growth factor production by the TC-1 cell line. Here we report the presence of a pre-B inducing activity and a number of known growth factors as detected by bioassay of conditioned medium or analysis of messenger RNA (mRNA) species by cDNA hybridization. In addition, we have defined IL-4 and granulocyte-CSF (G-CSF) as agents capable of inducing pre-B cells from murine marrow in liquid culture.
MATERIALS AND METHODS
Bone marrow cells were obtained from femoral and tibial blowouts from 6-to 8-week-old female BALB/c mice (Dominion Labs, Dublin, VA), CBA/J mice 5 to 8 weeks old, and BDF-1 mice 11 to 16 weeks of age (Jackson Labs, Bar Harbor, ME). Cells were flushed from bones with RPMI 1640 (GIBCO, Grand Island, NY) supplemented with 2 mmol/L L-glutamine, vitamins, 1 mmol/L sodium pyruvate, nonessential amino acids, 0.05 mmol/L 2-mercaptoethanol, penicillin, streptomycin, and 5% prescreened fetal calf serum (FCS).
Conditioned medium from rat hybridoma line 14.8 (ATCC, Rockville, MD), concentrated 10-fold on an Amicon XM-50 membrane (Amicon, Danvers, MA) was the source of 14.8 antibodie~.~~,~' Monoclonal antibody (MoAb) 14.8 recognizes epitopes on murine pre-B and B cells and some T lymphocytes. This MoAb recognizes the B220 surface glycoprotein. Affinity-purified goat anti-mouse immunoglobulin (Ig) and anti-rat Ig were obtained from Southern Biotechnology Associates, Birmingham, AL. These antibodies were used for depleting B and pre-B cells by panning. A monoclonal rat anti-IL-4 antibody, affinity purified from conditioned medium (CM) from the hybridoma 11B11, was provided by Dr W.E. Paul (National Institutes of Health, Bethesda, MD), and a control rat MoAb was provided by Dr E. Vitetta RPMI 1640 medium with 5% FCS, essential and nonessential amino acids, 200 mmol/L L-glutamine, vitamins, 5 x mol/L 2-mercaptoethanol, and penicillin and streptomycin usually at 1 x lo6 cells/mL. Different growth factors or antibodies were added at varying levels and cultures harvested after 18 or 42 hours of growth at 37oC and 5% CO,, cell counts determined, and immunofluorescent staining performed. All data were calculated as the absolute number of pre-B cells per lo6 cells cultured.
Surface Ig+ cells were detected by staining of cytospin slide preparations with FITC-conjugated affinity purified goat anti-mouse IgG. Cytoplasmic p chains of IgM were detected using TRITC-conjugated affinity purified goat-anti-mouse p. Pre-B cells were designated as nongranular, mononuclear cells that were surface Ig negative and positive for the presence of cytoplasmic p chains. Immunofluorescence was scored on a Zeiss fluroescent microscope (Zieler Instrument Co, Boston, MA). In initial studies p+ cells were scored (in general the sIg subtract did not change results). Subsequently, pre-B cells were scored as cytoplasmic p+ and surface Ig-. In more recent studies the presence of cytoplasmic light chains was determined using FITC-conjugated anti-X and anti-n antibodies.
Murine marrow was harvested and suspended in RPMI 1640,5% FCS, and additives as described above at a concentration of 10 x lo6 cells/mL.26 This cell suspension was underlayed with 1 part Ficoll-Paque (Pharmacia, Piscataway, NJ) to 3 parts cell suspension and then centrifuged for 30 minutes at 1,000 rpm, 2OOC. The light density mononuclear cell fraction ( > I g/cm3) was collected, washed three times with RPMI (10% FCS), resuspended in RPMI, 10% FCS with penicillin and streptomycin at a concentration of 5 x IO6 cells/mL, and incubated overnite in Corning 25020 Petri dishes in a total volume of 4 mL. Nonadherent cells were removed the next morning and were over 90% (depleted) free of macrophages as determined by nonspecific esterase staining of pre-and postadherence cells. The cells were then subjected to panning to remove surface Ig and 14.8+ cells exactly as described above, except that only one panning step with 14.8 (v the usual two) was performed. In this step over 95% of surface Ig'and p+ cells were removed. This nonadherent, B, and pre-B depleted population of cells was then subjected to a T-lymphocyte complement lysis step using the T-cell specific antibodies Lyt 1.2 and Lyt 2.2 (Cedarlam Labs, Ontario, Canada). Cells were suspended in RPMI and 10% heat inactivated FCS with 1500 dilutions of anti Lyt 1.2 and anti Lyt 2.2 on ice, and after 30 minutes the cells were pelleted, resuspended in the same volume of 6% pretested baby rabbit complement (Pelfreeze), and incubated for 1 hour at 37OC. The cells were then washed in RPMI and 10% FCS plus 1% penicillin and streptomycin, and then resuspended in RPMI and 10% heatinactivated FCS.
Initial studies showed the Lyt 1.2 and 2.2 plus complement killed over 95% of murine thymocytes. It was difficult to show a killing effect on marrow cells because of the very low percentage of surface Lyt 1.2 and 2.2 positive marrow T cells (less than 2.5%). When Balb/c marrow cells were treated with Lyt 1.2 and Lyt 2.2 plus complement there was an apparent 46% (to 1.34%) decrease in this population, but this is admittedly close to background with marrow. Based on the thymocyte data we assume a killing of 95% or greater.
Total cellular RNA was extracted from cultured TC-l cells using the guanidine thiocyanate plus sarkosyl extraction t e c h n i q~e .~' .~~ Cells were exposed to guanidine thiocyanate in tissue culture flasks, the cell lysates pooled, and then ultracentrifuged (33,000 rpm at 150°C for 24 hours) on a Cesium chloride cushion. The RNA was then further purified by a series of salt and ethanol precipitations and phenol/chloroform/isoamyl alcohol extractions. Poly A+ RNA was selected by oligo-DT chromatography. Total or poly A+ RNA was electrophoresed in For personal use only. on April 26, 2017. by guest www.bloodjournal.org From methyl mercuric hydroxide or formamide agarose gels. The gel was capillary blotted onto zeta bind paper and further electroblotted overnight. Poly A + or whole RNA from EL-4 cells previously exposed to phorbol myristate acetate or from WEHI-3 cells served as positive controls for GM-CSF and IL-3 expression, respectively. The hybridization probes were: (1) A 750-base pair (bp) fragment of the murine GM-CSF c D N A~~ (pGM5'19 provided by Dr N. Cough, Ludwig Institute, Melbourne, Australia) prepared by BamHl and EcoRi digestion of plasmid pJL4; (2) a full-length murine G-CSF cDNA3' (provided by S. Nacata, Osaka, Japan) prepared by excision of the 1,400-bp fragment from the plasmid pMG-2 using EcoRi; (3) a 3,500-bp fragment of murine CSF-I cDNA (Cetus Corp, Emeryville, CA) prepared by digestion of pGEM2 with EcoRi"; (4) An 1,104-bp cDNA for IL-632 (DNAX, Palo Alto, CA) excised from the plasmid pGEM-3 by digestion with BamHl and Pstl; (5) a nearly full-length (488 bp) cDNA for murine IL-3 (DNAX) excised from pcDVl using Ne01 and HindII133; and (6) a 1,633 bp insert of the IL-5 cDNA excised from pcDSR with BamHl. These probes were labeled using a random primed DNA labeling kit (Boehringer Mannheim, Mannheim, Germany) and 32P CTP (New England Nuclear, Boston, MA). Blots were hybridized overnight at 65°C. Serial washes at 65OC were then performed with: (1) 0.5% bovine serum albumin, 0.5% sodium dodecyl sulfate (SDS), 40 mmol/L phosphate buffer: (2) 1% SDS, 40 mmol/L phosphate buffere, and 1 mmol/L EDTA, and (3) 40 mmol/L phosphate buffer. Blots were then exposed to Kodak XAR-S film with an intensified screen for varying time intervals. An oligonucleotide for IL-7 was purchased from Amgen, labeled with "PdATP, and used for hybridization as described above.
Long-term lymphoid cultures. Lymphocytes were harvested from long-term cultures of BALB/c bone marrow 3 to 7 weeks after initiati~n.'~.'' Typically, the cells include less than 10% B cells, 10% to 30% pre-B cells, and earlier B-lineage progenitors that have already begun Ig heavy chain rearrangement^.'^ In most experiments, the lymphocytes were harvested from cultures that had been selected for low expression of the B220 antigen, and in one experiment, the lymphocytes were depleted of 14.8+ cells by panning. Freshly harvested lymphocytes were washed and resuspended at room temperature in culture medium (RPMI 1640, 5% selected FCS (Hyclone lot no. 110451), 5 x lo-' 2-mercaptoethanol, and antibiotics. Lymphocytes, 1.3 x IO6, were placed in each well of Costar 48 well tissue culture plates. Concentrated dialyzed supernates from TC-1 cells were added to final concentrations of 10%. For comparison, 50% CM from the harvested long-term cultures was added in some experiments. The cells were incubated 18 to 24 hours at 37OC and 5% CO,. The cells were collected, counted, and scored for the expression of B220, sIgM, and cytoplasmic p. Directly fluoresceinated MoAb 331.12 was used to detect sIgM. Because of the inherent variability of culture phenotypes in this system,35 the data were compiled from five separate experiments. The average increase in antigen expression was calculated by determining the number of positive cells per million plated initially, and the ratio of experimental to control cells (fresh medium only) is presented.
Data are presented as the mean + 1 SE of the mean of separate experiments." One to two individual cultures were pooled for the data in each experiment. Statistical significance was determined using the signed ranks test devised by Wilcoxon; p = probability (randomization frequency) in both tails combined.
Statistics.
RESULTS
C M from the TC-1 cell line reproducibly stimulated pre-B cell formation over 18 hours of culture (Table 1) . Similar results were obtained at 42 hours of culture or if marrow harvested from mice 3 or 8 days after intravenous administration of 150 mg/kg 5-fluorouracil was assayed (data not shown). C M depleted of CSF-1 was fully active (Table 1) . C M partially purified for CSF-1 and IL-3 synergistic activity by separation or DEAE cellulose, Concanavalin A, G-100 Sephadex, and anti-CSF chromatography induced pre-B cells in liquid culture. Light density marrow cells depleted of adherent, B, pre-B, and T cells, while showing higher background pre-B levels, responded to TC-1 C M by generating high levels of pre-B cells ( Table 2) .
TC-1 contains GM-CSF, CSF-1 (Fig l ) , IL-4, and probably G-CSF (Table 3 ). There is also present another B-cell differentiating activity, termed B-cell stimulatory factor (BSF-TC), which is physically separable from the pre-B and CSF-1 synergizing activity described here.3s As noted above, preparations free of CSF-1 had pre-B activity. Recombinant GM-CSF has no pre-B inducing activity (117% * 18% of control in three experiments). Similarly, both IL-3, rhIL-6, Stimulation of pre-B cell generation from nonadherent cells from long-term lymphoid marow cultures. In the presence of TC-I CM. lymphocytes from Whitlock-Witte type cultures were stimulated to generate pre-B cells ( ( Table 4 ). There was a lesser effect on slg' cells. and CM from the Whitlock-Witte cultures had marginal effects on pre-B cell generation. Pre-B generation from these nonadherent cells was quite variable but was consistently stimulated by TC-I CM as compared with control cultures or cultures exposed to 50% CM from the Whitlock-Witte cultures. No differences were found between experiments using lymph@ cytes from Whitlock-Witte cultures that were unseparated or had been depleted of 14.8' cells by panning, and these were therefore pooled for presentation in Table 4 . Supernates from clonesoftheTC-I cell line(TC-I-C3 andTC-I-C-I I)*were also effective in stimulating an increase in 14.8' p* cell frequency (data not shown).
Eflects of IL-4 on in vitro pre-B cell generation. Crude preparations of IL-4 or recombinant IL-4 have pre-B inducing activity in this assay system against both unseparated ( Table 5 ) and separated adherent B-and T-cell4epleted marrow (Table 6) . Results similar to those presented in Tables 5 and 6 against unseparated marrow were Seen at 5. For personal use only. on April 26, 2017. by guest www.bloodjournal.org From 100, and 400 U/mL rIL-4 using either w+ or p+ surface Ig, or cytoplasmic light chain negative criteria for pre-B cells. However, an MoAb to IL-4 that blocked pre-B induction by rIL-4 or EL-4 supernates did not block pre-B induction by TC-1 C M (Fig 2) . This indicates that while IL-4 is a pre-B inducer in this assay system the pre-B inducer in TC-1 C M is probably not IL-4.
G-CSF was also found to be an inducer of pre-B cells in this culture system (Table 7) , although depletion of accessory cells removed or markedly diminished this effect, suggesting that it might be due to growth factor induction by accessory cells.
DISCUSSION
Dexter et a14' and Whitlock and Witte4* culture systems present models for regulation of myeloid and lymphoid differentiation, respectively. Adherent stromal cells are necessary in each system for ongoing cell production and appear to selectively support early hamatopoietic stem cells. Explant Dexter stroma or cell lines derived from Dexter or WhitlockWitte cultures appear capable of producing a variety of hemolymphopoietic growth factors, including CSF-1, G-CSF, GM-CSF, IL-6, IL-I, and IL-7, which may be involved in early stem cell regulation.39.40*44.
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The present studies indicate that a stromal cell line, TC-1, isolated from stromal cultures under conditions approaching lymphoid permissiveness, produces GM-CSF, CSF-1, G-CSF, IL-4, and a pre-B inducing activity. This cell line also produces a CSF-1 and IL-3 synergistic activity,2 and this synergistic activity segregates with a pre-B activity through three biochemical separative steps. The pre-B activity may or may not be identical with the synergistic activity but appears to be separate from CSF-1, GM-CSF, and G-CSF as determined by selective bioassay, antibody blocking, and differences in molecular size. G-CSF has pre-B inducing activity but, as opposed to the TC-1 pre-B activity, appears to act indirectly via accessory cells and has a much lower apparent molecular weight. Supernatants from the TC-1 cell For personal use only. on April 26, 2017. by guest www.bloodjournal.org From 
